|
Volumn 20, Issue 2, 2002, Pages 260-267
|
Persistent asthma: Disease control, resource utilisation and direct costs
a a a a a a a |
Author keywords
Asthma; Control; Health economics; Resource utilisation; Severity; Therapy
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
ADOLESCENT;
ADULT;
ANAMNESIS;
ARTICLE;
ASTHMA;
COMORBIDITY;
CONTROLLED STUDY;
COST OF ILLNESS;
DATA ANALYSIS;
DATA BASE;
DEMOGRAPHY;
DISEASE CONTROL;
DISEASE SEVERITY;
FEMALE;
FRANCE;
GENERAL PRACTICE;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH SURVEY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RESOURCE ALLOCATION;
RETROSPECTIVE STUDY;
ECONOMICS;
HEALTH BEHAVIOR;
HOSPITALIZATION;
MIDDLE AGED;
OUTCOME ASSESSMENT;
STATISTICS;
ADOLESCENT;
ADULT;
ASTHMA;
COST OF ILLNESS;
FEMALE;
FRANCE;
HEALTH BEHAVIOR;
HEALTH CARE COSTS;
HUMAN;
MALE;
MIDDLE AGE;
OUTCOME ASSESSMENT (HEALTH CARE);
RESOURCE ALLOCATION;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
SUPPORT, NON-U.S. GOV'T;
HUMANS;
MIDDLE AGED;
|
EID: 0035989744
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.02.02542001 Document Type: Article |
Times cited : (124)
|
References (25)
|